Novel small molecule epithelial sodium channel inhibitors as potential therapeutics in cystic fibrosis – a patent evaluation

Author： Schoenberger Matthias   Althaus Mike  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.10, 2013-10, pp. : 1383-1389

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Molecule Inhibitors of PKC&thgr; as Potential Antiinflammatory Therapeutics

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 7, 2009-05 ,pp. : 640-654

Bentham Science Publishers

Access to resources Recommend Favorite

Patent developments in antimycobacterial small-molecule therapeutics

By van Daele Ineke   van Calenbergh Serge  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 2, 2005-02 ,pp. : 131-140

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Kinase Inhibitors as Anti-Cancer Therapeutics

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 5, 2012-05 ,pp. : 399-411

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Approaches for Potential Therapy of Cystic Fibrosis

By  

Current Drug Targets, Vol. 16, Iss. 9, 2015-01 ,pp. : 923-936

Bentham Science Publishers

Access to resources Recommend Favorite

Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review

By Mane Uttam Rajaram   Gupta Ramesh C   Nadkarni Sunil Sadanand   Giridhar Rajani R   Naik Prashant Prakash   Yadav Mange R  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 2, 2013-02 ,pp. : 165-187

Informa Healthcare

Access to resources Recommend Favorite